There are many resources and services in place at UAMS and the Myeloma Institute to help ensure seamless visits for our patients and their families.
Our specialized and experienced staff provides superb medical attention in an atmosphere of friendliness and compassion. Our clinical and basic program is unique in creating rapid application of scientific breakthroughs to treating multiple myeloma patients. The quality of the Myeloma Institute’s innovative clinical and basic research is known nationally and internationally.
The Myeloma Institute is headed by Dr. Bart Barlogie, M.D., Ph.D., one of the world’s leading experts in the diagnosis and treatment of multiple myeloma. Dr. Barlogie and his staff are finding out more and more about myeloma every day and are committed to finding innovative ways to treat the disease. They refuse to settle for anything less than the best for their patients, just one of the reasons people from all over the world come here for treatment.
The Myeloma Institute for Research and Therapy, evolving from the breakthrough advances of the UAMS myeloma program, is committed to accelerating curative therapies for multiple myeloma and related disease entities through innovative clinical and basic science research and outstanding patient care.